IQV vs UNH

IQVIA exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a highly attractive PEG ratio of 0.68, suggesting significant undervaluation relative to its growth. While the stock is currently trading at a premium to its Graham Number ($82.24), it sits well below its intrinsic value ($231.28) and analyst targets ($231.60). However, the bullish fundamental outlook is contrasted by a severe technical downtrend and liquidity concerns, evidenced by a current ratio of 0.75 and high leverage. Overall, the company's robust ROE and consistent earnings growth make it a strong value play despite short-term price volatility.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.